background
respiratori
viral
infect
rvi
frequent
complic
hematopoiet
stem
cell
transplant
hsct
surgic
mask
simpl
inexpens
intervent
may
reduc
nosocomi
spread
method
prospect
singlecent
studi
institut
univers
surgic
mask
polici
requir
individu
direct
contact
hsct
patient
wear
surgic
mask
regardless
symptom
season
primari
endpoint
incid
rvi
mask
period
compar
premask
period
result
rvi
decreas
patient
premask
period
mask
period
p
signific
decreas
occur
allogen
p
autolog
p
transplant
adjust
multipl
covari
includ
season
year
segment
longitudin
analysi
decreas
rvi
remain
signific
risk
rvi
patient
mask
group
compar
premask
group
p
contrast
decreas
observ
period
adjac
hematolog
malign
unit
follow
infect
control
practic
except
mask
polici
major
decreas
parainfluenza
viru
p
conclus
requir
individu
direct
patient
contact
wear
surgic
mask
associ
reduct
rvi
particularli
vulner
period
follow
hsct
respiratori
viral
infect
rvi
signific
complic
hematopoiet
stem
cell
transplant
hsct
affect
patient
addit
caus
rhiniti
cough
symptom
case
progress
lower
respiratori
tract
infect
associ
mortal
high
hsct
recipi
immunocompromis
tightli
cohort
vulner
nosocomi
spread
exampl
number
report
cluster
outbreak
parainfluenza
viru
type
within
hsct
unit
mani
case
molecular
epidemiolog
analys
trace
outbreak
singl
hand
strain
spread
persontoperson
transmiss
standard
infect
control
procedur
serv
essenti
role
curtail
rvi
hypothes
may
insuffici
prevent
nosocomi
spread
patient
caregiv
provid
may
shed
viru
yet
asymptomat
therefor
miss
standard
droplet
precaut
focu
symptomat
patient
similarli
strategi
increas
infect
control
measur
winter
influenza
respiratori
syncyti
viru
rsv
season
neglect
peak
summer
hsct
unit
experienc
higherthanaverag
incid
rvi
prompt
explor
mean
better
prevent
transmiss
hypothes
institut
infect
control
protocol
requir
univers
surgic
mask
usag
yearround
individu
contact
patient
peritranspl
would
complement
exist
measur
eg
univers
hand
wash
provid
greater
protect
rvi
transmiss
follow
approv
duke
univers
health
system
institut
review
board
conduct
prospect
intervent
trial
impact
univers
surgic
mask
usag
rvi
polici
ad
standard
infect
control
practic
implement
monitor
duke
hospit
epidemiolog
infect
control
figur
univers
mask
polici
requir
individu
direct
patient
contactmed
support
staff
visitor
caregiv
patientsto
wear
surgic
mask
standard
earloop
mask
within
feet
hsct
patient
similar
mask
shown
reduc
aerosol
shed
coars
fine
viru
particl
patient
requir
wear
mask
travel
outsid
room
univers
surgic
mask
usag
institut
hsct
inpati
bed
outpati
day
hospit
bed
unit
associ
wait
room
complianc
reinforc
nurs
train
design
washout
period
monitor
period
independ
observ
use
protocol
monitor
hand
hygien
complianc
focu
reduc
nosocomi
transmiss
patient
caregiv
requir
wear
mask
alon
home
alon
privat
room
univers
surgic
mask
usag
institut
decemb
allow
week
implement
washout
mask
cohort
includ
patient
transplant
januari
januari
conserv
washout
period
would
expect
significantli
greater
incub
period
respiratori
viral
pathogen
interest
patient
receiv
transplant
decemb
earliest
date
data
avail
electron
record
novemb
consid
premask
cohort
patient
observ
start
condit
pretranspl
prepar
chemotherapi
andor
radiat
complet
peritranspl
care
discharg
condit
prophylaxi
graftvshost
diseas
gvhd
discharg
criteria
clinic
protocol
unchang
cours
studi
signific
chang
number
bed
either
hematologyoncolog
unit
bone
marrow
transplant
unit
cours
studi
patient
respiratori
symptom
test
via
nasopharyng
wash
sputum
cultur
tracheal
aspir
bronchoalveolar
lavag
presenc
viru
determin
direct
fluoresc
antigen
dfa
cultur
polymeras
chain
reaction
pcr
combin
dfa
cultur
limit
pcr
influenza
b
parainfluenza
viru
piv
type
adenoviru
rsv
test
metapneumoviru
rhinoviru
coronaviru
perform
exclud
analysi
death
due
rvi
determin
blind
review
medic
record
physician
data
obtain
medic
record
duke
hsct
databas
duke
enterpris
data
unifi
content
explor
databas
baselin
characterist
summar
number
percentag
categor
variabl
mean
standard
deviat
median
rang
continu
variabl
differ
continu
baselin
characterist
premask
mask
cohort
examin
use
wilcoxon
ranksum
test
independ
nonparametr
sampl
continu
variabl
normal
distribut
differ
categor
baselin
characterist
incid
rvi
percentag
posit
test
result
death
due
rvi
examin
use
test
fisher
exact
test
appropri
investig
effect
season
yeartoyear
variat
rvi
conduct
timeseri
analysi
patient
observ
time
broken
longitudin
way
interv
signifi
singl
season
spring
summer
fall
winter
singl
locat
inpati
outpatientday
hospit
number
interv
per
patient
rang
patient
procedur
treatment
outpati
cours
singl
season
patient
hospit
cours
sever
season
account
unequ
number
observ
point
vari
length
total
observ
time
segment
neg
binomi
model
exchang
correl
structur
exposur
time
total
number
day
observ
use
examin
incid
rvi
quasiakaik
inform
criterion
analysi
use
determin
best
correl
structur
segment
regress
model
use
type
model
may
abl
explain
appar
differ
due
extern
effect
quantifi
use
tradit
multipl
regress
model
time
segment
day
start
studi
day
postintervent
patient
premask
cohort
given
valu
postintervent
time
patient
demograph
clinic
variabl
examin
covari
multivari
model
myeloabl
condit
use
alemtuzumab
umbil
cord
transplant
haploident
transplant
gvhd
relev
allogen
hsct
allohsct
third
level
ad
variabl
indic
autolog
hsct
autohsct
perform
level
exclud
fit
model
due
collinear
type
transplant
variabl
code
variabl
like
patient
exclud
model
primari
endpoint
incid
rvi
peritranspl
period
incid
examin
secondari
endpoint
major
rvi
fell
categori
model
result
present
incid
rate
ratio
confid
interv
ci
ci
calcul
use
robust
standard
error
adjust
made
multipl
comparison
statist
analys
conduct
use
sa
softwar
version
sa
institut
cari
north
carolina
stata
softwar
version
statacorp
colleg
station
texa
nine
hundr
twenti
patient
includ
premask
cohort
mask
cohort
tabl
group
balanc
term
sex
though
mask
cohort
tend
older
mean
age
vs
year
p
includ
patient
multipl
myeloma
p
result
greater
proport
receiv
autohsct
overal
incid
rvi
drop
premask
cohort
mask
cohort
p
tabl
decreas
primarili
drop
p
also
decreas
rsv
decis
test
viral
pathogen
depend
patient
sign
symptom
clinician
concern
viral
infect
surpris
therefor
concurr
decreas
rvi
fewer
viral
test
perform
mask
period
howev
despit
increas
sensit
pcrbase
test
mask
period
proport
posit
test
result
lower
test
posit
premask
posit
test
compar
januari
januari
p
data
total
test
perform
avail
last
year
thu
includ
calcul
suggest
test
practic
rvi
aggress
mask
period
rate
rvi
truli
lower
substanti
season
yearli
variat
incid
rvi
figur
exampl
piv
tend
peak
summer
wherea
rsv
influenza
peak
winter
year
eg
particularli
sever
outbreak
piv
wherea
year
eg
saw
case
rule
possibl
season
yearli
variat
confound
analysi
conduct
timeseri
analysi
adjust
covari
season
year
well
age
locat
type
transplant
allohsct
condit
intens
tcell
deplet
donor
gvhd
tabl
use
model
mask
use
estim
reduc
risk
rvi
adjust
covari
p
signific
variabl
season
condit
intens
gvhd
also
use
model
evalu
interact
season
mask
use
found
impact
mask
intervent
greatest
summer
p
supplementari
tabl
found
interact
locat
inpati
vs
outpati
mask
use
supplementari
tabl
suggest
impact
mask
use
depend
locat
also
found
interact
locat
type
transplant
allov
autohsct
supplementari
tabl
analys
also
perform
look
endpoint
interest
supplementari
tabl
mask
use
estim
reduc
risk
adjust
covari
p
evalu
impact
addit
univers
mask
usag
standard
infect
control
procedur
compar
occurr
hsct
popul
rest
hospit
use
mask
part
standard
droplet
precaut
symptomat
patient
figur
premask
period
among
hsct
patient
track
close
rest
hospit
howev
univers
surgic
mask
polici
institut
number
infect
drop
significantli
among
hsct
patient
wherea
remain
high
rest
hospit
univers
mask
usag
hsct
patient
account
hospitalwid
infect
drop
implement
p
also
compar
hsct
popul
neighbor
hematolog
malign
unit
ident
infect
control
practic
except
univers
surgic
mask
usag
supplementari
figur
rvi
neighbor
unit
actual
increas
time
wherea
decreas
hsct
popul
data
neighbor
unit
avail
prior
juli
complianc
univers
surgic
mask
usag
extrem
high
among
healthcar
provid
compliant
per
observ
among
patientscaregiv
adjust
model
also
control
time
start
studi
decemb
time
start
intervent
januari
day
unadjust
model
includ
mask
use
control
potenti
yeartoyear
variat
season
condit
intens
presenc
gvhd
mask
use
statist
signific
impact
rvi
bold
bold
p
valu
variabl
significantli
associ
incid
viral
infect
abbrevi
allohsct
allogen
hematopoiet
stem
cell
transplant
autohsct
autolog
hematopoiet
stem
cell
transplant
ci
confid
interv
gvhd
graftvshost
diseas
hsct
hematopoiet
stem
cell
transplant
irr
incid
rate
ratio
rvi
respiratori
viral
infect
complianc
hand
hygien
also
consist
high
among
healthcar
provid
data
avail
patientscaregiv
although
modern
infect
control
practic
help
decreas
viral
infect
curtail
outbreak
rvi
remain
problemat
hsct
standard
prevent
method
includ
strict
hand
hygien
vaccin
activ
earli
surveil
contact
droplet
isol
symptomat
patient
howev
strategi
focu
symptom
address
prolong
asymptomat
shed
rvi
immunocompromis
patient
includ
rang
day
therefor
surpris
symptombas
surveil
isol
polici
report
mix
result
one
prolong
outbreak
fred
hutchinson
cancer
research
center
droplet
isol
aggress
screen
symptomat
patient
impact
durat
sever
outbreak
case
institut
contrast
success
seen
univers
surgic
mask
usag
institut
respons
outbreak
john
hopkin
sidney
kimmel
comprehens
cancer
center
given
effect
control
outbreak
univers
surgic
mask
usag
show
promis
inexpens
easytoimpl
prevent
addit
directli
stop
transmiss
viral
particl
univers
usag
may
drive
cultur
chang
provid
patient
heighten
awar
attent
import
infect
control
intervent
may
readili
appli
hsct
program
fact
institut
alreadi
requir
everyon
wear
surgic
mask
peak
winter
influenza
season
howev
common
spring
summer
month
nosocomi
outbreak
prolong
extend
beyond
typic
season
focu
winter
neglect
signific
proport
rvi
requir
univers
surgic
mask
usag
yearround
abl
significantli
reduc
rvi
hsct
biggest
impact
made
major
rvi
consist
report
literatur
also
found
gvhd
associ
rvi
gvhd
patient
receiv
addit
immunosuppress
includ
corticosteroid
myeloabl
condit
associ
fewer
rvi
patient
gener
healthier
ie
abl
toler
myeloabl
condit
interestingli
model
find
signific
differ
allohsct
autohsct
howev
model
control
inpatientoutpati
stay
take
account
length
interv
incid
rvi
allohsct
time
autohsct
length
stay
allohsct
time
autohsct
control
length
stay
minim
impact
type
transplant
limit
studi
beforeandaft
design
signific
differ
cohort
increas
preval
plasma
cell
dyscrasia
consequ
autohsct
mask
cohort
howev
univers
surgic
mask
usag
signific
protect
effect
within
autohsct
allohsct
subgroup
wherea
season
yearli
variat
rvi
may
also
bia
result
found
parallel
decreas
rest
hospit
thu
seem
unlik
natur
variat
rate
rvi
commun
account
observ
decreas
support
timeseri
analysi
found
decreas
risk
rvi
mask
period
account
covari
season
year
addit
diseas
type
transplant
variabl
addit
differ
detect
method
premask
period
predominantli
viral
cultur
dfa
vs
postmask
period
pcr
could
impact
result
howev
pcr
known
least
sensit
detect
viral
pathogen
compar
dfa
cultur
depend
pathogen
without
sacrif
specif
would
expect
bia
toward
null
true
effect
size
mask
intervent
thu
may
underrepres
current
studi
intervent
studi
design
direct
respons
rise
rvi
could
render
suscept
effect
seen
due
regress
mean
mitig
possibl
collect
data
extend
period
full
year
follow
implement
univers
mask
usag
rather
examin
simpli
season
year
consid
possibl
test
bia
result
reduc
vigil
screen
rvi
mask
period
howev
lower
proport
posit
test
result
mask
period
suggest
test
frequent
mask
periodthat
undertest
would
explain
decreas
rvi
also
consid
possibl
cours
studi
period
improv
hospitalwid
infect
control
effort
span
studi
respons
reduct
rvi
rate
hsct
patient
howev
concurr
reduct
rvi
observ
either
adjac
nonhsct
hematolog
malign
unit
hospitalwid
moreov
increas
use
sensit
specif
pcrbase
viral
diagnost
test
would
expect
increas
detect
rvi
univers
mask
period
seen
adjac
hematolog
malign
unit
contrast
observ
decreas
rvi
despit
increas
sensit
rais
possibl
underestim
protect
effect
univers
mask
usag
conclus
shown
univers
surgic
mask
usag
requir
individu
inpati
outpati
hsct
facil
direct
patient
contact
wear
surgic
mask
regardless
symptom
season
associ
signific
decreas
clinic
signific
rvi
particularli
suggest
univers
surgic
mask
usag
could
potent
adjunct
standard
infect
control
practic
bone
marrow
transplant
unit
supplementari
materi
avail
http
cidoxfordjournalsorg
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
author
